P-Tau and Subunit c Mitochondrial ATP Synthase Accumulation in the Central Nervous System of a Woman with Hurler–Scheie Syndrome Treated with Enzyme Replacement Therapy for 12 Years
- 29 April 2018
- book chapter
- Published by Springer Nature
- Vol. 41, 101-107
Abstract
We report an autopsy case of a woman with mucopolysaccharidosis type I (MPS I) Hurler–Scheie syndrome who was treated with enzyme replacement therapy (ERT) for 12 years. This was the first case of MPS I treated with ERT in Japan. Pathological analysis showed no glycosaminoglycan accumulation in the liver and spleen as a result of long-term ERT, although severe aortic stenosis, diffuse intimal hyperplasia of the coronary artery, and fibrous hypertrophy of the endocardium were observed. Additionally, we detected subunit c mitochondrial ATP synthase (SCMAS) accumulation and mild tauopathy (hyperphosphorylated tau or p-tau, both 3-repeat and 4-repeat tau accumulation) in the same area of the cerebral limbic system and central gray matter of the mid brain and pons. Tauopathy is an important pathological finding in Alzheimer’s disease and other neurodegenerative disorders; however, in MPS I, it is unclear whether tauopathy is a primary or secondary phenomenon. Thus, in this report, we describe pathological accumulation of p-tau and SCMAS in the context of MPS I and discuss the mechanisms and importance of these findings in the pathogenesis of MPS I.Keywords
This publication has 24 references indexed in Scilit:
- Enzyme replacement therapy (ERT) procedure for mucopolysaccharidosis type II (MPS II) by intraventricular administration (IVA) in murine MPS IIMolecular Genetics and Metabolism, 2012
- Sanfilippo syndrome type B, a lysosomal storage disease, is also a tauopathyProceedings of the National Academy of Sciences, 2009
- Lysosomal accumulation of SCMAS (subunit c of mitochondrial ATP synthase) in neurons of the mouse model of mucopolysaccharidosis III BMolecular Genetics and Metabolism, 2007
- Tauopathies: classification and clinical update on neurodegenerative diseases associated with microtubule‐associated protein tauInternal Medicine Journal, 2006
- Enzyme replacement therapy in mucopolysaccharidosis type IActa Paediatrica, 2005
- Enzyme replacement therapy in mucopolysaccharidosis type IActa Paediatrica, 2005
- Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human α-L-iduronidase (laronidase)The Journal of Pediatrics, 2004
- Immune tolerance after long-term enzyme-replacement therapy among patients who have mucopolysaccharidosis IThe Lancet, 2003
- Overexpression of the Human Lysosomal Enzyme α-L-Iduronidase in Chinese Hamster Ovary CellsProtein Expression and Purification, 1994
- Long‐term outcome of Hurler syndrome following bone marrow transplantationAmerican Journal of Medical Genetics, 1993